JP2007509116A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509116A5
JP2007509116A5 JP2006536167A JP2006536167A JP2007509116A5 JP 2007509116 A5 JP2007509116 A5 JP 2007509116A5 JP 2006536167 A JP2006536167 A JP 2006536167A JP 2006536167 A JP2006536167 A JP 2006536167A JP 2007509116 A5 JP2007509116 A5 JP 2007509116A5
Authority
JP
Japan
Prior art keywords
methyl
nitro
phenylamino
trifluoromethyl
ylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006536167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509116A (ja
Filing date
Publication date
Priority claimed from GBGB0324551.1A external-priority patent/GB0324551D0/en
Application filed filed Critical
Publication of JP2007509116A publication Critical patent/JP2007509116A/ja
Publication of JP2007509116A5 publication Critical patent/JP2007509116A5/ja
Pending legal-status Critical Current

Links

JP2006536167A 2003-10-21 2004-10-21 アンドロゲン受容体モジュレーター Pending JP2007509116A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0324551.1A GB0324551D0 (en) 2003-10-21 2003-10-21 Novel compounds
PCT/GB2004/004464 WO2005042464A1 (en) 2003-10-21 2004-10-21 Androgen receptor modulators

Publications (2)

Publication Number Publication Date
JP2007509116A JP2007509116A (ja) 2007-04-12
JP2007509116A5 true JP2007509116A5 (enExample) 2007-12-06

Family

ID=29595536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536167A Pending JP2007509116A (ja) 2003-10-21 2004-10-21 アンドロゲン受容体モジュレーター

Country Status (7)

Country Link
US (1) US20080058383A1 (enExample)
EP (1) EP1685090A1 (enExample)
JP (1) JP2007509116A (enExample)
AU (1) AU2004285744A1 (enExample)
CA (1) CA2543345A1 (enExample)
GB (1) GB0324551D0 (enExample)
WO (1) WO2005042464A1 (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554696C (en) 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
EP1737813A1 (en) 2004-04-13 2007-01-03 Warner-Lambert Company LLC Androgen modulators
WO2005102990A1 (en) 2004-04-22 2005-11-03 Warner-Lambert Company Llc Androgen modulators
MXPA06013115A (es) * 2004-05-11 2007-02-28 Pfizer Prod Inc Derivados de benzonitrilo para tratar la fragilidad musculoesqueletica.
CA2570047C (en) 2004-07-08 2010-09-28 Warner-Lambert Company Llc 4-cycloalkoxy benzonitriles as androgen modulators
WO2006044707A1 (en) * 2004-10-13 2006-04-27 Smithkline Beecham Corporation Chemical compounds
RU2007130558A (ru) 2005-01-10 2009-02-20 Акэдиа Фармасьютикалз Инк. (Us) Производные аминофенола в качестве селективных модуляторов андрогеновых рецепторов
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
WO2008012845A1 (en) 2006-07-26 2008-01-31 Stmicroelectronics S.R.L. Use of nitroaniline derivatives for the production of nitric oxide
US8268872B2 (en) 2008-02-22 2012-09-18 Radius Health, Inc. Selective androgen receptor modulators
MX2010009162A (es) 2008-02-22 2010-12-21 Radius Health Inc Moduladores selectivos del receptor de androgeno.
CN105012282A (zh) 2008-07-02 2015-11-04 不列颠哥伦比亚癌症局分支机构 二缩水甘油醚衍生物治疗剂和它们的使用方法
KR101239571B1 (ko) * 2008-11-24 2013-03-06 바스프 에스이 열잠재성 염기를 포함하는 경화성 조성물
KR20100067046A (ko) * 2008-12-10 2010-06-18 동화약품주식회사 신규한 ２，６―위치에 치환된 ３―니트로피리딘 유도체, 그의 제조방법 및 이를 포함하는 약학 조성물
AU2010203356B2 (en) * 2009-01-09 2015-11-26 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
US9962368B2 (en) 2009-01-09 2018-05-08 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
US8362277B2 (en) 2009-01-09 2013-01-29 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
US9162980B2 (en) 2009-01-09 2015-10-20 Board Of Regents Of The University Of Texas System Anti-depression compounds
TWI491606B (zh) 2009-07-13 2015-07-11 Gilead Sciences Inc 調節細胞凋亡信號之激酶的抑制劑
FR2954315B1 (fr) * 2009-12-23 2012-02-24 Galderma Res & Dev Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
FR2954317B1 (fr) 2009-12-23 2012-01-27 Galderma Res & Dev Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
FR2954316B1 (fr) 2009-12-23 2014-01-03 Galderma Res & Dev Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
AR079846A1 (es) 2010-01-06 2012-02-22 British Columbia Cancer Agency Agentes terapeuticos derivados de bisfenol que contienen un grupo aquiral y su uso en el tratamiento del cancer
CA2788907A1 (en) 2010-02-04 2011-08-11 Radius Health, Inc. Selective androgen receptor modulators
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
JP2013531801A (ja) * 2010-07-02 2013-08-08 ヴェンタナ メディカル システムズ， インク． 標的検出のためのハプテンコンジュゲート
US8642632B2 (en) 2010-07-02 2014-02-04 Radius Health, Inc. Selective androgen receptor modulators
AU2011274787B2 (en) 2010-07-07 2016-06-16 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
ES2550319T3 (es) 2010-09-28 2015-11-06 Radius Health, Inc Moduladores selectivos del receptor de andrógenos
US9365510B2 (en) 2012-04-16 2016-06-14 British Columbia Cancer Agency Branch Aziridine bisphenol ethers and related compounds and methods for their use
AU2013305591B2 (en) 2012-08-24 2017-04-13 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
KR20160054523A (ko) 2013-09-09 2016-05-16 브리티쉬 콜롬비아 캔써 에이전시 브랜치 암 영상화 및 치료용 할로겐화 화합물, 및 이들의 사용 방법
EP3068388A4 (en) 2013-11-11 2017-04-12 Board of Regents of the University of Texas System Neuroprotective compounds and use thereof
WO2015070237A1 (en) 2013-11-11 2015-05-14 Board Of Regents Of The University Of Texas System Neuroprotective chemicals and methods for identifying and using same
RS67458B1 (sr) 2014-03-28 2025-12-31 Univ Duke Lečenje kancera dojke pozitivnog na receptor estrogena upotrebom selektivnih modulatora receptora estrogena
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
WO2016106384A1 (en) 2014-12-23 2016-06-30 Gilead Sciences, Inc. Processes for preparing ask1 inhibitors
ES2907708T3 (es) 2015-01-13 2022-04-26 British Columbia Cancer Agency Branch Compuestos heterocíclicos para obtención de imágenes y tratamiento del cáncer y métodos para su uso
WO2016141458A1 (en) 2015-03-12 2016-09-15 British Columbia Cancer Agency Branch Bisphenol ether derivatives and methods for using the same
KR102676629B1 (ko) 2015-04-29 2024-06-18 래디어스 파마슈티컬스, 인코포레이티드 암을 치료하는 방법
US20170298033A1 (en) 2016-04-15 2017-10-19 The University Of British Columbia Bisphenol derivatives and their use as androgen receptor activity modulators
RS63311B1 (sr) 2016-06-22 2022-07-29 Ellipses Pharma Ltd Ar+ metode lečenja raka dojke
KR102881465B1 (ko) 2017-01-05 2025-11-04 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
CN110770210A (zh) 2017-05-18 2020-02-07 Pi工业有限公司 新颖的脒化合物
WO2019226991A1 (en) 2018-05-25 2019-11-28 Essa Pharma, Inc. Androgen receptor modulators and methods for their use
CN112423844B (zh) 2018-07-04 2024-08-13 雷迪厄斯制药公司 Rad1901-2hcl的多晶型形式
CN118684633A (zh) 2018-10-18 2024-09-24 埃萨制药股份有限公司 雄激素受体调节剂及其使用方法
JOP20210218A1 (ar) 2019-02-12 2023-01-30 Radius Pharmaceuticals Inc عمليات ومركبات
US12109179B2 (en) 2019-03-28 2024-10-08 Essa Pharma Inc. Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
WO2021212032A1 (en) 2020-04-17 2021-10-21 Essa Pharma, Inc. Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970423A (en) * 1971-10-04 1976-07-20 Clairol Incorporated Oxidative hair dye compositions
CA1012553A (en) 1972-06-23 1977-06-21 Hirotoshi Nakanishi Process for the production of aromatic diamines
JPS4920129A (enExample) * 1972-06-23 1974-02-22
US4723986A (en) * 1986-05-19 1988-02-09 Stauffer Chemical Company Herbicidal oxazolidines and methods of use
JP2701090B2 (ja) * 1990-11-30 1998-01-21 和光純薬工業株式会社 被酸化性呈色試薬
JPH0580375A (ja) * 1991-09-20 1993-04-02 Japan Synthetic Rubber Co Ltd 有機非線形光学素子
JPH0920129A (ja) * 1995-07-05 1997-01-21 Suzuki Motor Corp 車両用暖房装置
DE19612506A1 (de) 1996-03-29 1997-10-02 Wella Ag Oxidationshaarfärbemittel mit einem Gehalt an 2,5-Diaminobenzonitrilen sowie neue 2,5-Diaminobenzonitrile
RU2220960C2 (ru) * 1997-12-22 2004-01-10 Фармация Энд Апджон Компани 4-гидрокси-3-хинолинкарбоксамиды и гидразиды, фармацевтическая композиция и способ лечения на их основе
US20020193389A1 (en) * 1998-11-20 2002-12-19 Rifat Pamukeu Method of inhibiting neoplastic cells with imidazoquinazoline derivatives
US6472415B1 (en) * 1998-12-18 2002-10-29 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
GB0004887D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
CA2420279C (en) * 2000-08-24 2011-07-19 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof
JP2004514656A (ja) * 2000-09-06 2004-05-20 カイロン　コーポレイション グリコゲンシンターゼキナーゼ３のインヒビター
CA2469316A1 (en) * 2001-12-07 2003-06-19 Vertex Pharmaceuticals, Inc. Pyrimidine-based compounds useful as gsk-3 inhibitors
DE10163251A1 (de) * 2001-12-21 2003-07-03 Henkel Kgaa Neue Entwicklerkomponenten

Similar Documents

Publication Publication Date Title
EP2516398B1 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
US5776951A (en) Anti-atherosclerotic diaryl compounds
JP2015526487A5 (enExample)
CZ20032727A3 (cs) Derivát karboxylové kyseliny a jeho sůl
FR2954315A1 (fr) Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
EP1731506A1 (en) 5-hydroxyindole-3-carboxylates derivatives and their use
JP7443414B2 (ja) アンドロゲン受容体のｎ末端ドメインの阻害剤
JP2007509116A (ja) アンドロゲン受容体モジュレーター
CS242881B2 (en) Method of 1,4-dihydropyridine's new derivatives production
SK13752002A3 (sk) Difenyléterové zlúčeniny užitočné pri liečení
CZ334998A3 (cs) Substituované benzylaminy a farmaceutický prostředek
CN1192728A (zh) 苯基烷烃酰胺衍生物及农业或园艺杀菌剂
SK285037B6 (sk) Spôsob výroby 2-aryl-3-aryl-5-halogénpyridínov
TWI284127B (en) Cyclization process for substituted benzothiazole derivatives
CN1197864C (zh) 吡唑并哒嗪衍生物的制备方法
CN1317265C (zh) 氰基丙烯酸酯衍生物及制备方法和生物活性
CN1533378A (zh) 制备喹唑啉的方法
CN107848968B (zh) 从乙醛酸制备内酰胺的方法
EP2516400B1 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
TWI884201B (zh) 用於製備3-溴-1-(3-氯吡啶-2-基)-1h-吡唑-5-羧酸乙酯的方法
AU2010303243A1 (en) Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds
CN1166650C (zh) 1,2,3-噻二唑类化合物及其制备方法和生物活性
EP1928869B1 (en) Chemical process
CN100363347C (zh) 作为治疗剂的4-(1-(磺酰基)-1h-吲哚-2-基)-4-(羟基)-环己-2,5-二烯酮化合物及其类似物
CN1939127A (zh) 取代苯基异噁唑类除草剂